Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VCYT
Stock Latest News
The Fly
Veracyte initiated with a Hold at Canaccord
13h ago
VCYT
Premium
The Fly
Veracyte initiated with a Buy at Freedom Capital
4d ago
VCYT
Premium
The Fly
Veracyte announces results from BALANCE trial of PAM50
22d ago
VCYT
Premium
The Fly
Veracyte reports Phase 3 STAMPEDE trial finding published in Cell
2M ago
VCYT
Premium
The Fly
Veracyte meets targeted enrollment for NIGHTINGALE trial
2M ago
VCYT
Premium
The Fly
Veracyte management to meet with Craig-Hallum
2M ago
VCYT
Premium
Ratings
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns
2M ago
VCYT
Premium
The Fly
Veracyte price target lowered to $28 from $29 at Morgan Stanley
2M ago
VCYT
Premium
Ratings
Veracyte’s Strong Clinical Evidence and Market Growth Justify Buy Rating
2M ago
VCYT
Premium
Company Announcements
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones
2M ago
VCYT
Premium
Ratings
Veracyte’s Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
2M ago
VCYT
Premium
Ratings
Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating
2M ago
VCYT
Premium
Company Announcements
Veracyte Reports Strong Q2 2025 Revenue Growth
2M ago
VCYT
Premium
The Fly
Veracyte sees FY25 revenue $477M-$483M, consensus $491.92M
3M ago
VCYT
Premium
The Fly
Veracyte reports Q2 EPS 44c, consensus 30c
3M ago
VCYT
Premium
Market News
BMNR, VCYT, ZG: Cathie Wood Buys $15M More of Ethereum-Linked Bitmine
3M ago
ZG
XYZ
Premium
Market News
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
3M ago
ABSI
ARKG
Premium
The Fly
Veracyte to replace Triumph Group in S&P 600 at open on 7/29
3M ago
TGI
VCYT
Premium
Company Announcements
Veracyte Stockholders Approve Key Decisions at Annual Meeting
4M ago
8K
VCYT
Premium
The Fly
Veracyte to present multiple abstracts at ASCO
5M ago
VCYT
Premium
Ratings
Cautious Outlook on Veracyte: Sell Rating Amid Market Pressures and Execution Risks
5M ago
VCYT
Premium
Company Announcements
Veracyte Inc. Reports Strong Q1 2025 Earnings
5M ago
VCYT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
